;

Auto Summaries - Symptoms
Last updated: 2024 Nov 18
Total hit(s): 18859
S.No.
1
38787317
Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38626299
Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38709953
Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
39520876
Erratum to 'Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study'.
N/A
Int J Infect Dis
2024 Nov 8
3.42
1
5
39495325
Reflections on awake prone positioning in COVID-19: considerations on body inclination, respiratory support, and patient variability.
N/A
Intensive Care Med
2024 Nov 4
8.61
1
6
39545819
Correction to: Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination.
N/A
Clin Infect Dis
2024 Nov 15
7.71
1
7
38979807
Anti-rubella IgG serum levels predict risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infections.
N/A
Allergy
2024 Nov
8.7
1
8
39393107
Poor stress resilience as an independent risk factor for severe COVID-19 and respiratory infections.
N/A
J Psychosom Res
2024 Oct 9
4.8
1
9
39360871
Letter Regarding: Long-Term Corneal Endothelial Parameters of COVID-19 Patients With Ocular Surface Symptoms.
N/A
Cornea
2024 Oct 3
2
1
10
39447273
Letter to the Editor: "Portal hypertension-like pattern in coronavirus disease 2019 acute respiratory distress syndrome".
N/A
J Crit Care
2024 Oct 23
2.83
1
11
39447388
Corrigendum to "Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins" [International Journal of Infectious Diseases (2023), volume 131, 87-94].
N/A
Int J Infect Dis
2024 Oct 23
3.42
1
12
39425101
Correction: Long COVID is not the same for everyone: a hierarchical cluster analysis of long COVID symptoms 9 and 12 months after SARS-CoV-2 test.
N/A
BMC Infect Dis
2024 Oct 18
2.58
1
13
39415603
Metabolic dysfunction-associated steatotic liver disease and BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant: correspondence.
N/A
J Gastroenterol Hepatol
2024 Oct 17
3.4
1
14
39401742
Risk of Acute Aortic Events Following COVID-19 and Influenza Respiratory Viral Infections: Comment.
N/A
Ann Vasc Surg
2024 Oct 12
1.18
1
15
39390426
Correction: COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
N/A
BMC Infect Dis
2024 Oct 10
2.58
1
16
39389773
Evidence for a Link of COVID-19-Associated Long-Term Neurologic Symptoms and Altered Brain Integrity?
N/A
AJNR Am J Neuroradiol
2024 Oct 10
3.38
1
17
39352650
Response to the Letter to the Editor Regarding "Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study".
N/A
Infect Dis Ther
2024 Oct 1
3.95
1
18
39389680
New Evidence for SARS-CoV-2 Vaccine Boosting in Patients With Chronic Lung Diseases.
N/A
Chest
2024 Oct
7.22
1
19
39229889
Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient.
N/A
Scand J Rheumatol
2024 Sep 4
1
20
39329278
Updated consensus statement for China pulmonary rehabilitation of coronavirus disease 2019 (2023).
N/A
Chin Med J (Engl)
2024 Sep 27
1.053
1
21
39222134
Comparative efficacy of prolonged versus shorter awake prone positioning in managing acute respiratory failure in COVID-19 Patients. A Clinical Assessment.
N/A
Intensive Care Med
2024 Sep 2
8.61
1
22
39222140
Awake prone positioning for COVID-19 patients with acute respiratory failure: unknown appropriate duration.
N/A
Intensive Care Med
2024 Sep 2
8.61
1
23
39269351
[Nirmatreolvir-ritonavir (Paxlovid) leads to no reduction of symptoms or hospitalizations in vaccinated or unvaccinated high-risk adults with Covid-19.].
N/A
Recenti Prog Med
2024 Sep
0.7
1
24
39269353
[Molnupiravir reduces symptoms duration but does not decrease hospitalizations or deaths in vaccinated adults with Covid-19.].
N/A
Recenti Prog Med
2024 Sep
0.7
1
25
39112468
Structural basis for the interaction between human coronavirus HKU1 spike receptor binding domain and its receptor TMPRSS2.
N/A
Cell Discov
2024 Aug 8
4.65
1